Current medical research and opinion
-
Comparative Study
Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments.
To compare opioid utilization and healthcare costs over a 1-year period following the initiation with duloxetine versus other standard of care (SOC) treatments among patients with diabetic peripheral neuropathic pain (DPNP). ⋯ Among commercially-insured DPNP patients, duloxetine-treated patients had delayed and reduced opioid use and lower healthcare costs than SOC-treated patients.